General practitioner views of an electronic high-risk medicine proforma to facilitate information transfer

Int J Clin Pharm. 2015 Feb;37(1):4-7. doi: 10.1007/s11096-014-0033-8. Epub 2014 Nov 14.

Abstract

Background: The potential of warfarin related harm is increased if clinicians lack the full patient specific information to make informed decisions-an e-proforma has been developed to communicate this information on hospital discharge.

Objective: To determine the views of general practitioners (GPs) on a warfarin discharge e-proforma.

Method: A cross-sectional survey of all GPs (n = 272) within the Raigmore Hospital catchment area of NHS Highland, Scotland.

Results: The response rate was 39.3 % (107/272). 84 (78.5 %) noticed recent changes to information supplied on discharge for warfarin patients. 64 (59.8 %) respondents thought this would result in more informed prescribing with regards to dosing, while 65 (60.7 %) felt this would improve safety. Accurate completion, timely receipt of the e-proforma and a realistic date for subsequent INR tests were considered important by GPs.

Conclusion: This study suggests the use of an e-proforma to communicate information about a high-risk medication, warfarin, to GPs on discharge optimises safe, informed prescribing and monitoring in primary care. The development of a discharge e-proforma for other high-risk medication as a patient safety improvement measure should be explored.

MeSH terms

  • Attitude of Health Personnel*
  • Continuity of Patient Care / standards*
  • Continuity of Patient Care / trends
  • Cross-Sectional Studies
  • Electronic Health Records / standards*
  • Electronic Health Records / trends
  • General Practitioners / standards*
  • General Practitioners / trends
  • Humans
  • Patient Discharge / standards*
  • Patient Discharge / trends
  • Surveys and Questionnaires
  • Warfarin / adverse effects*

Substances

  • Warfarin